James Harper Net Worth & Insider Trades

James Harper - Director, Corcept Therapeutics Inc

As of July 12, 2010

What is James Harper's Net Worth?

The current estimated net worth of Corcept Therapeutics Inc's Director, James Harper, is estimated to be about $151.8K . James Harper owns about 65,400 units of Corcept Therapeutics Inc common stock. In the last 6 years at Corcept Therapeutics Inc, James Harper has sold an estimated value of $0 worth.

What is James Harper's Past Insider Trading?

James Harper's largest purchase order was 50,000 units , worth over $50K on April 3, 2007. In total, James Harper has made about 9 transactions over 6 years of their time at Corcept Therapeutics Inc. James Harper usually trades in June, with the busiest year in 2006 and 2007.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is James Harper's' Mailing Address?

  • Mailing address is 11158 Parkside Crescent Carmel IN 46032 IN

Corcept Therapeutics Inc Executive Compensation

Name
Year
Salary
Bonus
Option Awards
Other Compensation
Total
Joseph K. Belanoff, M.D., 2020 $769,567 $744,000 $4,237,643 $10,892 $5,762,102
Joseph K. Belanoff, M.D., 2019 $707,525 $745,290 $3,506,155 - $4,958,970
Joseph K. Belanoff, M.D., 2018 $679,792 $477,750 $5,157,075 - $6,314,617
Andreas Grauer, M.D., 2020 $454,550 $219,157 $1,271,293 $118,274 $2,063,274
Andreas Grauer, M.D., 2019 $362,267 $243,720 $3,115,335 $78,245 $3,799,567
Hazel Hunt, Ph.D., 2020 $431,873 $243,000 $2,084,640 - $2,759,513
Sean Maduck, 2020 $474,380 $214,157 $2,508,404 - $3,196,941
Sean Maduck, 2019 $456,133 $308,881 $1,476,276 - $2,241,290
Sean Maduck, 2018 $436,667 $198,000 $2,171,400 - $2,806,067
Charles Robb, 2020 $474,380 $321,236 $2,118,822 - $2,914,438
Charles Robb, 2019 $456,133 $308,881 $1,845,345 - $2,610,359
Charles Robb, 2018 $436,667 $237,600 $2,171,400 - $2,845,667
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1088856/000162828021007363/a2021def14a.htm

What are Corcept Therapeutics Inc's Past Insider Trades?

Corcept Therapeutics Inc's most recent insider trade came on December 5, 2022 by Sean Maduck who sold 625 units worth $15.8K . In the last 18 years, insiders at Corcept Therapeutics Inc have sold an estimated value of $197.04M and bought an estimated value of $187.04M worth of shares. Insider trading is most common in February, with the busiest year in 2006. The most active traders at the company are Joseph K Belanoff, Chief Executive Officer,  Robert Roe, President and Secretary,  and Leonard Baker Jr, Director .

CORCEPT THERAPEUTICS INC Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1